logo
Urgent warning as researchers find cancer-causing formaldehyde in dozens of common hygiene products

Urgent warning as researchers find cancer-causing formaldehyde in dozens of common hygiene products

Daily Mail​08-05-2025

An urgent warning has been issued to millions of women after the known carcinogen, formaldehyde was found in dozens of popular personal care products.
While experts have long been concerned about the presence of the substance in chemical hair-straightening and relaxing treatments, a new study has revealed it is in far more products, including shampoo, lotions, body soap, and even eyelash glue.
Formaldehyde, a toxin used as a preservative, can escape from products in gas form over time - especially when coming into contact with heat - and if it is then inhaled, it can cause anything from minor side effects like eye and respiratory irritation, to major health issues like an increased risk of head and neck cancers if exposure occurs repeatedly.
These risks are heightened in areas which are poorly ventilated.
The American Cancer Society notes that in animal and human studies, formaldehyde has been linked to various forms of cancer including in the nose, the upper throat, the stomach and it has also been shown to increase the risk of leukemia.
In the recent study by the Silent Spring Institute - an organization dedicated to uncovering the environmental causes of breast cancer - 70 black and latina women living in the Los Angeles area were asked to track their use of personal care products over a period of five to seven days.
Each time participants used a product, they logged the information in a smartphone app developed by Silent Spring. The app also prompted the participants to take a photo of each ingredient label.
The team analyzed over 1,100 products, looking for formaldehyde and formaldehyde releasing preservatives - chemicals that gradually release formaldehyde over time - in the products' ingredient lists.
Fifty-three per cent of participants reported using at least one personal care product that listed formaldehyde releasers on its label.
Worryingly, many of the products with formaldehyde releasers participants reported they were using daily or multiple times per week.
The researchers did not divulge which exact products they tested.
DMDM hydantoin was the most common formaldehyde releasing preservative.
Roughly 47 per cent of skincare products and 58 per cent of hair products with formaldehyde-releasing preservatives contained DMDM hydantoin.
The team also identified several others, but exposure scientist Dr Robin Dodson has stressed their list is not definitive.
Dodson said: 'Those are just the ones we knew to look for. There could be more that we're not aware of.'
Companies add formaldehyde to personal care products in order to extend their shelf-life, formaldehyde-releasing preservatives are used as an alternative but serve the same purpose.
Given that formaldehyde is known to cause cancer in humans, the study authors say the findings reveal critical safety gaps in how personal care products are regulated in the U.S. and their disproportionate health impacts on women of color, as most of the products found to contain these substances cater to black and latina women.
Dodson said: 'We found that this isn't just about hair straighteners. These chemicals are in products we use all the time, all over our bodies.
'Repeated exposures like these can add up and cause serious harm.'
The cancer expert says one way to reduce exposure would be to require that companies add warning labels to formaldehyde-releasing products like they do in Europe.
She understands it can be hard for the average consumer - and even chemists - to identify a formaldehyde releasing preservative on a label.
Dodson added: 'They have long, weird, funny names, and they typically don't have the word formaldehyde in them.'
While warning labels might be a good first step, Dodson says banning the use of formaldehyde releasers altogether would be the best-case option.
She said: 'Ideally, companies shouldn't be putting these chemicals in products in the first place.'
Researchers added that another way consumers can protect themselves and their communities is to advocate for better legislation to be introduced.
The European Union and at least 10 U.S. states have banned or proposed to ban formaldehyde and formaldehyde releasers in personal care products.
In 2023, the Food And Drug Administration proposed a national ban on formaldehyde and formaldehyde releasers in hair straighteners, but it is yet to be enacted.
The study was part of a larger effort called the Taking Stock Study, a community-engaged research collaboration between Occidental College, Black Women for Wellness, Silent Spring, and Columbia University.
The project investigates how exposures to chemicals in beauty products contribute to health inequities for black women and latinas in California.
Janette Robinson Flint, the executive director at Black Women For Wellness, said black consumers live in a society governed by white beauty standards.
For this reason, she claims that they use many different personal care products - many of them made with toxic ingredients - to conform to that ideal.
Flint said: 'We're trying to do the right thing.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Lions LB Malcolm Rodriguez (knee) out until November
Lions LB Malcolm Rodriguez (knee) out until November

Reuters

time25 minutes ago

  • Reuters

Lions LB Malcolm Rodriguez (knee) out until November

June 5 - Detroit Lions linebacker Malcolm Rodriguez will not return from his knee injury until November, head coach Dan Campbell said Thursday. "He's not going to be starting the season out," Campbell said when asked about a timetable for Rodriguez, who tore his right ACL in last year's Thanksgiving game. "Conservatively? November. ... Yeah, that's probably the best way to say it. Probably November. Somewhere in there." Rodriguez, 26, recorded 43 tackles and 2.0 sacks in 10 games (six starts) before sustaining the season-ending injury in Detroit's 23-20 holiday victory over the rival Chicago Bears in Week 13. The 2022 sixth-round draft pick has tallied 151 tackles, 3.0 sacks, two forced fumbles and two fumble recoveries in 43 career games (24 starts) for the Lions. --Field Level Media

Four Democratic-led US states urge FDA to remove abortion pill restrictions
Four Democratic-led US states urge FDA to remove abortion pill restrictions

Reuters

time41 minutes ago

  • Reuters

Four Democratic-led US states urge FDA to remove abortion pill restrictions

NEW YORK, June 5 (Reuters) - The attorneys general of New York, California, Massachusetts and New Jersey asked the Food and Drug Administration to expand access to the abortion pill mifepristone, and remove what they view as outdated and medically unnecessary restrictions. Thursday's petition by the Democratic-led states seeks to force the FDA to acknowledge what the states view as "extensive" evidence that mifepristone is safe, notwithstanding the Trump administration's general opposition to abortion. It came after Health and Human Services Secretary Robert F. Kennedy Jr told Congress last month he ordered FDA Commissioner Marty Makary to review the pill, and unspecified "alarming" new data suggested the government should at least change the label. Mifepristone is the first pill, followed by the drug misoprostol, for medication abortion in the first 10 weeks of pregnancy, and won FDA approval in 2000. Medication abortions account for more than half of U.S. abortions, though 28 states restrict access, according to the nonprofit Guttmacher Institute, which focuses on reproductive health. The petition challenges FDA requirements that mifepristone prescribers be included in national and local abortion provider lists, patients attest in writing that they intend to end their pregnancies, and pharmacies perform a variety of recordkeeping. Citing the drug's safety record, it said those rules, part of the FDA's Risk Evaluation and Mitigation Strategy program, are "no longer justified by science or law," especially in states where abortion is legal and comprehensively regulated. New York Attorney General Letitia James said the rules keep mifepristone out of reach of most primary care settings. She called that problem particularly acute in rural and other areas where getting abortions often requires lengthy travel. "There is simply no scientific or medical reason to subject it to such extraordinary restrictions," James said, referring to mifepristone. "The FDA must follow the science." A spokeswoman for the Department of Health and Human Services said FDA Commissioner Makary "will ensure gold standard science is used while incorporating practical, common-sense considerations to its regulatory processes." Many states, primarily Republican-led or leaning, have restricted or substantially eliminated abortions in the three years since the U.S. Supreme Court overturned Roe v. Wade, the 1973 decision that legalized the procedure nationwide. Last June, the Supreme Court preserved broad access to mifepristone, unanimously ruling that a group of anti-abortion organizations and doctors lacked legal standing to challenge the FDA's approval of the pill. Despite largely siding with abortion opponents, Republican President Donald Trump said during his 2024 campaign he did not plan to limit access to mifepristone. Last month, the administration asked a federal judge to dismiss, on procedural grounds, a lawsuit by three generally Republican states seeking to narrow such access. That lawsuit began during the administration of Democratic President Joe Biden, who generally supported abortion access. Seventeen other Democratic-led or -leaning states plus Washington, D.C., are separately suing the FDA in Spokane, Washington, to loosen restrictions on mifepristone. They said doctors and pharmacies should be able to dispense the pill, as with most drugs, without special certifications. On May 30, the Trump administration urged a dismissal, saying the states didn't show the FDA's policy was flawed or the agency ignored important evidence. The states filed Thursday's petition after a short delay, with the filing having been expected earlier in the morning.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store